Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
Denmark
100%
8-oxoguanine
95%
Type 2 Diabetes Mellitus (T2DM)
74%
Type 2 Diabetic Patients
46%
Oxidative Stress
45%
Placebo
44%
Glucagon-like
43%
95% Confidence Interval
43%
Glucose-dependent Insulinotropic Polypeptide
41%
National Cohort Study
41%
Oxidative DNA Damage
40%
Paracetamol
34%
Antipyrine
32%
Meta-analysis
30%
During Pregnancy
30%
Urinary Excretion
28%
Pharmacokinetics
27%
Randomized Placebo-controlled Trial
26%
Odds Ratio
25%
N-acetylcysteine
25%
Randomized Clinical Trial
24%
Glucagon
23%
Randomized Controlled Trial
22%
Adverse Drug Reaction
22%
Metabolism
21%
Hazard Ratio
21%
Medication Review
21%
Metformin
20%
COVID-19
19%
Paracetamol Overdose
19%
Placebo-controlled
19%
RNA Oxidation
19%
Oxidative Stress Markers
18%
DNA Damage
18%
Hospitalization
17%
Confidence Interval
17%
Poison Control Centers
17%
Randomized Double-blind
17%
Healthy Individuals
16%
1 Receptor
16%
Polypharmacy
16%
Glucose-lowering Drugs
16%
Hemoglobin A1c (HbA1c)
16%
Plasma Concentration
16%
Capital Region
15%
Adverse Events
15%
Obesity
15%
Adverse Effects
15%
Hospitalized Patients
14%
Urinary Markers
14%
Vitamin C
14%
Cystic Fibrosis
14%
Healthy Controls
13%
Anabolic Steroids
13%
Randomized Trial
13%
Medication Use
13%
RNA Damage
13%
Older Patients
13%
Smokers
13%
High Dose
13%
DNA Oxidation
13%
Register Study
13%
Blood Pressure
13%
High Risk
12%
Opioids
12%
Comorbidity
12%
Nucleic Acid Oxidation
12%
Metronidazole
12%
Oxazepam
12%
Antipsychotics
12%
Prescription Drugs
12%
Polymorphism
11%
Selective Serotonin Reuptake Inhibitors
11%
Risk Factors
11%
Liver
11%
Cytochrome P450 1A2 (CYP1A2)
11%
Gastric Emptying
11%
Receptor Agonist
11%
Glucose-dependent Insulinotropic Polypeptide Receptor
11%
Copenhagen
11%
Nationwide Registry
11%
Non-associated
11%
Vitamin E
11%
Cytochrome P450 2D6 (CYP2D6)
10%
Type 1 Diabetes Mellitus (T1DM)
10%
Type I Diabetes
10%
Blood Samples
10%
Bipolar Disorder
10%
Acetaminophen
10%
Liraglutide
10%
Congenital Malformations
10%
Activated Charcoal
10%
Scoping Review
10%
Major Congenital Malformations
10%
University Hospital
10%
Tramadol
9%
Cerebrospinal Fluid
9%
Plasma Glucose
9%
Drug Interactions
9%
Low-density Lipoprotein Cholesterol (LDL-C)
9%
Pharmacology, Toxicology and Pharmaceutical Science
Toxic Injury
81%
Paracetamol
77%
Cohort Study
74%
Maturity Onset Diabetes of the Young
67%
Placebo
63%
Pharmacokinetics
63%
Rat
61%
8 Hydroxydeoxyguanosine
57%
Adverse Event
46%
Gastric Inhibitory Polypeptide
38%
Adverse Drug Reaction
30%
Malignant Neoplasm
30%
Glucose
28%
Phenazone
28%
Biological Marker
27%
Diseases
27%
Congenital Malformation
24%
Antioxidant
24%
Prevalence
24%
Ascorbic Acid
23%
Elimination
22%
Pharmacotherapy
21%
Glutathione
20%
Poison Control Centers
20%
N-Acetylcysteine
19%
Nucleic Acid
19%
Polypharmacy
18%
Normal Human
18%
Randomized Controlled Trial
18%
Lipid
18%
Insulin
17%
Cardiovascular Disease
16%
Gastric Inhibitory Polypeptide Receptor
15%
Metronidazole
15%
Infection
14%
Enzymes
14%
Antipsychotic
14%
CYP2D6
14%
Pharmacodynamics
14%
Side Effect
13%
Drug Metabolism
13%
Glucagon Like Peptide 1 Receptor Agonist
12%
Drug Information
12%
Observational Study
12%
CYP1A2
12%
Activated Carbon
12%
Guanosine
12%
Glucagon-Like Peptide-1
12%
Creatinine
12%
Hepatotoxicity
12%
Oxazepam
11%
Congestive Heart Failure
11%
Spontaneous Abortion
11%
Glucagon
11%
Clinical Trial
10%
Asthma
10%
Cystic Fibrosis
10%
Chronic Obstructive Lung Disease
10%
Antimicrobial Agent
10%
Tramadol
10%
Guanine
10%
Selective Serotonin Reuptake Inhibitor
10%
Cytochrome
10%
Alpha Tocopherol
10%
Nucleoside
9%
Androgen
9%
CYP2C19
9%
Sodium
9%
Metoprolol
9%
High Performance Liquid Chromatography
9%
Receptor Antagonist
9%
Statin (Protein)
9%
Low Density Lipoprotein Cholesterol
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
9%
Drug-Drug Interaction
9%
Antidepressant
9%
Cytochrome P450
8%
Corticosteroid
8%
Liposome
8%
Randomized Clinical Trial
8%
Analgesic Agent
8%
Defined Daily Dose
8%
Deoxyguanosine
8%
Sodium Glucose Cotransporter 2 Inhibitor
8%
Bile Acid
8%
Inflammation
8%
Fluvoxamine
8%
Metformin
8%
Insulin Dependent Diabetes Mellitus
7%
Messenger RNA
7%
Antibiotics
7%
Liver Cirrhosis
7%
Genotoxicity
7%
Sucrose
7%
Morbidity
7%
Cimetidine
7%
CYP2E1
7%
Methylphenidate
7%
Schizophrenia
7%
Therapeutic Drug Monitoring
7%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
62%
Cohort Analysis
44%
Placebo
38%
Glucose
33%
Gastric Inhibitory Polypeptide
30%
Patient with Type 2 Diabetes
27%
Urinary System
22%
Glucagon Like Peptide 1
21%
Oxidative Stress
19%
Randomized Clinical Trials
18%
Hazard Ratio
17%
Insulin
17%
Glycon
17%
Infusion
16%
Adverse Event
16%
COVID-19
14%
Oral
14%
8 Hydroxydeoxyguanosine
13%
Body Mass Index
13%
Diseases
12%
Randomized Controlled Trial
12%
Diabetes
12%
Urinary Excretion
12%
Polypharmacy
12%
Systematic Review
12%
Biological Marker
11%
Lifestyle Intervention
11%
Odds Ratio
11%
Food Intake
11%
Insulin Dependent Diabetes Mellitus
10%
Prevalence
10%
Post-Hoc Analysis
10%
Congenital Malformation
10%
Meta-Analysis
10%
Cardiovascular System
10%
Glucagon
9%
Inflammation
9%
Clinical Trial
9%
Outpatient
9%
Breast Cancer
9%
Bile Acid
9%
Obesity
8%
Hemoglobin A1c
8%
Hypoglycemia
8%
Cardiovascular Disease
8%
Breast Implant
8%
Blood Pressure
8%
Arm
8%
Nucleic Acid
8%
Drug Therapy
8%
DNA Damage
8%
Intensive Care Unit
7%
Quality of Life
7%
Hypertension
7%
Comorbidity
7%
Adolescence
7%
Emergency Department
7%
Physical Activity
7%
Diabetes Mellitus
7%
Glycemic Control
7%
Body Weight
7%
Cystic Fibrosis
7%
Cosmetics
7%
Knee Arthroplasty
7%
Coronary Artery Disease
7%
Spontaneous Abortion
7%
Antioxidant
7%
Glucagon-Like Peptide-1 Agonist
7%
Health Care
6%
Observational Study
6%
Cell Function
6%
Gut
6%
Proportional Hazards Model
6%
Low Drug Dose
6%
Infection
6%
Osteolysis
6%
Placebo-Controlled Study
6%
Receptor
6%
Sodium Glucose Cotransporter 2 Inhibitor
6%
Small for Gestational Age
6%
Lipid
6%
Deoxyguanosine
6%
Neurodevelopmental Disorder
6%
Hyperglycemia
5%
Sodium-Glucose Cotransporter 2 Inhibitors
5%
Case-Control Study
5%
Androgen
5%
Hip Arthroplasty
5%
Liraglutide
5%
Geriatrics
5%
Remdesivir
5%
Bipolar Disorder
5%
Malignant Neoplasm
5%
Cancer
5%
Congestive Heart Failure
5%
Creatinine
5%
Receptor Antagonist
5%
Low Density Lipoprotein Cholesterol
5%
Apoplexy
5%
Glucose Metabolism
5%